Five-year incidence of cataract in older persons with diabetes and pre-diabetes
(Switzerland) Altimmune (US) Glenmark Pharmaceuticals Ltd (India) Biocon (India) Teva Pharmaceuticals (Israel) MARKET SCOPE WHAT IS IN IT FOR YOU: GLP-1 Agonists Market REPORT CONTENT GUIDE DELIVERED CUSTOMIZATIONS We have successfully delivered the following deep-dive customizations: RECENT DEVELOPMENTS September 2025 : Novo Nordisk (Denmark) received EU approval for its oral GLP-1 receptor agonist drug, Rybelsus, to reduce cardiovascular death, heart attack, and stroke
Prepared by the editors of Harvard Health Publishing in consultation with Chika V
parasites leads to the development of all symptoms associated with malaria, hence most antimalarials developed to date target the parasite in its blood stages
Key Features: Contains Akkermansia muciniphila, a beneficial gut bacteria strain that enhances the mucin layer of the gut lining, improving gut barrier integrity and reducing intestinal permeability
Thats where liraglutide often claims a practical advantage: Proven track record: Over a decade of realworld dataincluding pediatric approval down to age 12gives providers more confidence in longterm safety monitoring